newsfilter
← Latest News
PR Newswire·

UCB Showcases Strength of the Expanding Dermatology Portfolio at the 31st EADV Congress

20 abstracts highlight research in key disease areas including psoriasis and psoriatic arthritis New three-year data to be presented on bimekizumab in the treatment of moderate to severe plaque psoriasis BRUSSELS and ATLANTA, Sept. 1, 2022 /PRNewswir